| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A new delivery system to resolve dosimetric issues in intravascular brachytherapy
|
DeCunha, Joseph M.
|
|
2018
|
17 |
3 |
p. 634-643
|
article
|
| 2 |
A Phase II trial of 8 weeks of degarelix for prostate volume reduction: Efficacy and hormonal recovery
|
Korzeniowski, M.A.
|
|
2018
|
17 |
3 |
p. 530-536
|
article
|
| 3 |
Appropriate timing for postimplant imaging in permanent breast seed implant: Results from a serial CT study
|
Watt, Elizabeth
|
|
2018
|
17 |
3 |
p. 609-614
|
article
|
| 4 |
Assessment of a source position checking tool for the quality assurance of transfer tubes used in HDR 192Ir brachytherapy treatments
|
Awunor, O.A.
|
|
2018
|
17 |
3 |
p. 628-633
|
article
|
| 5 |
Comparison of chronological changes in urinary function in patients who underwent low-dose-rate brachytherapy for prostate cancer—A randomized controlled trial of alpha-1 adrenoceptor antagonist alone versus combination with cyclooxygenase-2 inhibitor—
|
Tanaka, Nobumichi
|
|
2018
|
17 |
3 |
p. 537-543
|
article
|
| 6 |
Custom mold applicator high-dose-rate brachytherapy for nonmelanoma skin cancer—An analysis of 273 lesions
|
Olek Jr., David
|
|
2018
|
17 |
3 |
p. 601-608
|
article
|
| 7 |
Demonstration of simulated annealing optimization for permanent breast seed implant treatment planning
|
Roumeliotis, Michael
|
|
2018
|
17 |
3 |
p. 615-620
|
article
|
| 8 |
Early toxicity and health-related quality of life results of high-dose-rate brachytherapy as monotherapy for low and intermediate-risk prostate cancer
|
Gaudet, Marc
|
|
2018
|
17 |
3 |
p. 524-529
|
article
|
| 9 |
Editorial Board
|
|
|
2018
|
17 |
3 |
p. A4
|
article
|
| 10 |
Efficacy and the toxicity of the interstitial high-dose-rate brachytherapy in the management of recurrent keloids: 5-year outcomes
|
Jiang, Ping
|
|
2018
|
17 |
3 |
p. 597-600
|
article
|
| 11 |
Endoluminal high-dose-rate brachytherapy for locally recurrent or persistent esophageal cancer
|
Taggar, Amandeep S.
|
|
2018
|
17 |
3 |
p. 621-627
|
article
|
| 12 |
Image-guided adaptive brachytherapy in primary vaginal cancers: A monocentric experience
|
Huertas, Andres
|
|
2018
|
17 |
3 |
p. 571-579
|
article
|
| 13 |
Improving dose delivery by adding interstitial catheters to fixed geometry applicators in high-dose-rate brachytherapy for cervical cancer
|
Otter, Sophie
|
|
2018
|
17 |
3 |
p. 580-586
|
article
|
| 14 |
Interventional Radiation Oncology (IRO): Transition of a magnetic resonance simulator to a brachytherapy suite
|
Anderson, Roberta
|
|
2018
|
17 |
3 |
p. 587-596
|
article
|
| 15 |
Masthead
|
|
|
2018
|
17 |
3 |
p. A1
|
article
|
| 16 |
New approach of ultra-focal brachytherapy for low- and intermediate-risk prostate cancer with custom-linked I-125 seeds: A feasibility study of optimal dose coverage
|
Brun, Thomas
|
|
2018
|
17 |
3 |
p. 544-555
|
article
|
| 17 |
Quality of life up to 10 years after external beam radiotherapy and/or brachytherapy for prostate cancer
|
Freiberger, Carla
|
|
2018
|
17 |
3 |
p. 517-523
|
article
|
| 18 |
Single-institutional outcomes of adjuvant brachytherapy for Stage I endometrial cancer—Are outcomes consistent with randomized studies?
|
Dohopolski, Michael J.
|
|
2018
|
17 |
3 |
p. 564-570
|
article
|
| 19 |
Table of Contents
|
|
|
2018
|
17 |
3 |
p. A2-A3
|
article
|
| 20 |
Time-driven activity-based cost comparison of prostate cancer brachytherapy and intensity-modulated radiation therapy
|
Dutta, Sunil W.
|
|
2018
|
17 |
3 |
p. 556-563
|
article
|
Journal description